MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 138 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 2.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $758,000 | -59.0% | 610,937 | +1.6% | 0.00% | – |
Q1 2017 | $1,850,000 | -66.8% | 601,188 | -56.0% | 0.00% | -100.0% |
Q4 2016 | $5,578,000 | -2.0% | 1,367,192 | +52.5% | 0.00% | -50.0% |
Q3 2016 | $5,693,000 | +19.5% | 896,420 | +1.5% | 0.00% | 0.0% |
Q2 2016 | $4,763,000 | -35.0% | 883,573 | +0.9% | 0.00% | -33.3% |
Q1 2016 | $7,328,000 | -8.9% | 875,504 | -14.0% | 0.00% | 0.0% |
Q4 2015 | $8,042,000 | -2.3% | 1,017,971 | +5.3% | 0.00% | 0.0% |
Q3 2015 | $8,231,000 | -18.7% | 967,168 | +18.2% | 0.00% | -25.0% |
Q2 2015 | $10,121,000 | +8.0% | 818,559 | +3.7% | 0.00% | +33.3% |
Q1 2015 | $9,375,000 | +2.3% | 789,094 | -2.7% | 0.00% | 0.0% |
Q4 2014 | $9,168,000 | +40.4% | 811,378 | +9.1% | 0.00% | 0.0% |
Q3 2014 | $6,529,000 | +78.0% | 743,586 | +47.8% | 0.00% | +200.0% |
Q2 2014 | $3,668,000 | -13.5% | 503,088 | -40.2% | 0.00% | -50.0% |
Q1 2014 | $4,242,000 | -19.6% | 841,507 | -15.0% | 0.00% | 0.0% |
Q4 2013 | $5,279,000 | +2513.4% | 990,249 | +1756.0% | 0.00% | – |
Q3 2013 | $202,000 | -49.9% | 53,354 | -10.7% | 0.00% | – |
Q2 2013 | $403,000 | – | 59,757 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 5,000,000 | $20,400,000 | 4.19% |
Consonance Capital Management LP | 9,067,998 | $36,997,000 | 4.06% |
Lagoda Investment Management, L.P. | 1,522,529 | $6,212,000 | 2.13% |
INDUS CAPITAL PARTNERS, LLC | 1,050,000 | $4,284,000 | 0.56% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 9,072,877 | $37,017,000 | 0.32% |
GARRISON BRADFORD & ASSOCIATES INC | 77,700 | $317,000 | 0.29% |
Cannell & Co. | 1,572,978 | $6,418,000 | 0.23% |
Virtus ETF Advisers LLC | 179,625 | $733,000 | 0.22% |
LeJeune Puetz Investment Counsel LLC | 3,976 | $161,000 | 0.12% |
STONERIDGE INVESTMENT PARTNERS LLC | 221,838 | $905,000 | 0.12% |